Fred Hutch statement on FDA’s CAR T-cell decision – Newswise (press release)
|
Fred Hutch statement on FDA’s CAR T-cell decision
Newswise (press release) “While the Food and Drug Administration’s first approval of a CAR T-cell therapy impacted a relatively small number of pediatric and young adult patients, today’s decision opens the door for a cellular immunotherapy to treat adults with aggressive … |
LA Daily News |
Cascade of costs could push new gene therapy above $1 million per patient
LA Daily News Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country’s first gene therapy, Novartis’ Kymriah, a leukemia treatment approved in August. But the total costs of Kymriah and the … |